TERC and cancer: It is reported that approximately 85–90% of cancer types are telomerase-positive, which use its RNA subunit (termed TR or TERC) as a template and its telomerase reverse transcriptase (TERT) to maintain chromosomal end by adding 5′-GGTTAG-3′ hexanucleotides6, 7.